Avalo Therapeutics, Inc. (AVTX): SCHEDULE 13G/A filed May 15, 2026

Form type

SCHEDULE 13G/A

Filing date

May 15, 2026

Accession number

0000935836-26-000282

Filer

Avalo Therapeutics, Inc. (CIK 1534120)